A clinical study of MK-1289 in healthy adult men (MK-1289-001)
This study is testing a new medicine, called MK-1289, for the first time in people. Researchers want to understand if it's safe and how it works in the body. They are looking for healthy adult men aged 18 and over to take part. This early stage of research is important because it helps scientists learn about potential new treatments. It's hoped that MK-1289 might eventually help people who get COVID-19, but this study won't actually be treating COVID-19. Participants will be carefully monitored by a medical team. Taking part is always a personal choice, and your safety and well-being are the top priority.
At a glance
What is this study about?
This study is a very early stage of research looking into a new medicine called MK-1289. Think of it like taking a new car design for its first test drive – the main goal is to check how it works and if it's safe, not yet to see how fast it can go or how many miles per gallon it gets. Researchers will give MK-1289 to healthy adult men for the very first time to see how their bodies react to it. This includes understanding how the medicine is absorbed, what happens to it inside the body, and how the body gets rid of it.
The main purpose of this study is to gather important safety information. Researchers will be watching very closely for any side effects and will also be looking to see what dose of the medicine is well-tolerated. This kind of early research is a vital step in developing new medicines. Without these first studies, we wouldn't be able to discover treatments that could help people in the future.
While the medicine might eventually be used for conditions like COVID-19, this particular study isn't about treating COVID-19 itself. It's about laying the groundwork to see if MK-1289 is safe enough to be tested in further, larger studies with people who have the condition. Every new medicine goes through this careful process to make sure it's as safe and effective as possible.
Key takeaways
- This is a first-time test of a new medicine (MK-1289) in people.
- The study is about checking safety and how the body handles the medicine.
- Only healthy adult men (18+ years old) can join.
- It aims to lay groundwork for potential future COVID-19 treatments.
- Participation involves clinic stays and close medical monitoring.
- You can stop participating at any time.
Who may be eligible?
To be able to take part in this study, you must be a healthy adult man. This means you should generally be in good health, without any major ongoing medical conditions that could affect the study's results or your safety.
You need to be at least 18 years old. There isn't an upper age limit mentioned, but you would still need to meet all the health requirements. The study is specifically looking for men, so women are not able to participate in this particular research.
The medical team will do a thorough check-up to make sure you fit all the necessary criteria before you can join. This helps make sure the study gathers accurate information and that it is safe for you to take part.
- Are you an adult aged 18 or older?
- Are you a man?
- Do you generally consider yourself to be in good health?
- Are you able to commit to clinic stays and follow-up visits?
- Are you willing to have regular medical checks, including blood tests?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you'll first have a screening visit to check if you're suitable for the study. If you are, you'll then be admitted to a clinic where the study medicine, MK-1289, will be given for the first time. You'll stay at the clinic for a certain period, and during this time, doctors and nurses will closely monitor your health, take blood and urine samples, and conduct other tests to see how your body reacts to the medicine.
After you leave the clinic, there will likely be follow-up visits or phone calls to check on your well-being. The total length of your participation, including the time in the clinic and follow-up, will be explained in detail before you agree to join. You'll receive all study-related medical care and the study medicine at no cost to you.
Potential risks and benefits
Locations (1)
- —Belgium
Common questions
What is MK-1289?
MK-1289 is a new medicine being tested for the first time. Researchers want to understand how it works and if it's safe.
Will I get COVID-19 if I join this study?
No, this study is not designed to give you COVID-19. It's about testing a potential future treatment, not exposing you to the virus.
Will I be paid to take part?
Often, studies like this offer some payment for your time and travel, but you should ask the study team for details.
How long will I have to stay at the clinic?
The exact length of your stay will be explained by the study team, as it can vary depending on the study's plan.
What if I feel unwell during the study?
The medical team will be closely monitoring you. If you feel unwell, you should tell them immediately, and they will provide care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.